Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ruether · SciRah

Researcher profile · Semantic Scholar

D. Ruether

Share profile

D. Ruether — researcher profile on SciRah

h-index: 12
Works: 47
Citations: 889

Most-cited papers

EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
J. Rosenberg, S. Sridhar, Jing-Song Zhang, David C. Smith +16 more
2020Journal of Clinical Oncology281 citations Open access
Semantic Scholar
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.
H. Scher, X. Jia, K. Chi, R. de Wit +12 more
2011Journal of Clinical Oncology244 citations Open access
Semantic Scholar
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †
D. Bebb, S. Banerji, N. Blais, P. Desmeules +14 more
2021Current Oncology36 citations Open access
Semantic Scholar
Factors Influencing Yields of Progenitor Cells for Allogeneic Transplantation: Optimization of G-CSF Dose, Day of Collection, and Duration of Leukapheresis
J. Luider, Chris W. Brown, S. Selinger, D. Quinlan +5 more
1997Journal of Hematotherapy33 citations
Semantic Scholar
Canadian guideline on genetic screening for hereditary renal cell cancers.
M. Reaume, G. Graham, E. Tomiak, S. Kamel-Reid +21 more
2013Canadian Urological Association journal = Journal de l'Association des urologues du Canada32 citations Open access
Semantic Scholar
Virtual Cancer Care During the COVID-19 Pandemic in Alberta: Evidence From a Mixed Methods Evaluation and Key Learnings
L. Watson, S. Qi, Andrea Delure, C. Link +5 more
2021JCO Oncology Practice30 citations Open access
Semantic Scholar
What is the State of the Science on Physical Activity Interventions for Family Caregivers? A Systematic Review and RE-AIM Evaluation.
C. Cuthbert, K. King-Shier, D. Ruether, D. Tapp +1 more
2017Journal of Physical Activity and Health22 citations
Semantic Scholar
Using Autoregressive Integrated Moving Average (ARIMA) Modelling to Forecast Symptom Complexity in an Ambulatory Oncology Clinic: Harnessing Predictive Analytics and Patient-Reported Outcomes
L. Watson, S. Qi, A. Deiure, C. Link +4 more
2021International Journal of Environmental Research and Public Health19 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process.
J. Seah, N. Blais, S. North, Yasmin Rahim +5 more
2013Canadian Urological Association journal = Journal de l'Association des urologues du Canada19 citations Open access
Semantic Scholar
Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
M. Eszlinger, Paul Stewardson, J. McIntyre, A. Box +6 more
2021European Thyroid Journal17 citations Open access
Semantic Scholar
Unmet Needs of Adult Survivors of Childhood Cancers: Associations with Developmental Stage at Diagnosis, Cognitive Impairment, and Time from Diagnosis
Joanne L. Park, Y. Brandelli, K. B. Russell, K. Reynolds +3 more
2017Journal of Adolescent and Young Adult Oncology17 citations
Semantic Scholar
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
A. Boucher, S. Ezzat, S. Hotte, I. Rachinsky +12 more
2021Oral Oncology12 citations Open access
Semantic Scholar
Interim analysis of a phase I dose escalation trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an antibody drug conjugate (ADC), in patients (Pts) with metastatic urothelial cancer (mUC)
J. Rosenberg, E. Heath, R. Perez, J. Merchan +13 more
201612 citations Open access
Semantic Scholar
The Canadian Uro‐Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone‐refractory prostate cancer progressing after mitoxantrone/prednisone
F. Saad, D. Ruether, S. Ernst, S. North +4 more
2008BJU International11 citations
Semantic Scholar
Canadian Urologic Oncology Group (CUOG) phase II multi-center study using docetaxel/prednisone in the second line setting for metastatic hormone-refractory prostate cancer in patients progressing after first line mitoxantrone/prednisone
F. Saad, D. Ruether, S. Ernst, S. North +1 more
200511 citations
Semantic Scholar
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate Cancer.
R. Gagnon, E. K. Kish, Sarah Cook, Kosuke Takemura +16 more
2024Clinical Genitourinary Cancer10 citations Open access
Semantic Scholar
Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada
C. Vasquez, M. Kolinsky, Rume Djebah, M. Uhlich +12 more
2020BMJ Open10 citations Open access
Semantic Scholar
Exploring Gender Differences in Self-Reported Physical Activity and Health Among Older Caregivers.
C. Cuthbert, K. King-Shier, D. Tapp, D. Ruether +1 more
2017Oncology Nursing Forum10 citations
Semantic Scholar
1142: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Prior to Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer: Pathologic Outcomes and 3-Year Follow-Up Analyses
M. Gleave, K. Chi, J. Chin, E. Winquist +5 more
20078 citations
Semantic Scholar
Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma
Kathryn Corbett, D. Ruether, I. Seiden-Long, G. Kline
2024Calcified Tissue International6 citations
Semantic Scholar
Renewing caregiver health and wellbeing through exercise (RECHARGE): A randomized controlled trial.
C. Cuthbert, K. King-Shier, D. Tapp, D. Ruether +2 more
2016Contemporary Clinical Trials6 citations
Semantic Scholar
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.
S. North, N. Basappa, G. Bjarnason, N. Blais +18 more
2013Canadian Urological Association journal = Journal de l'Association des urologues du Canada6 citations Open access
Semantic Scholar
Extensive necrotizing fasciitis associated with sunitinib therapy.
Jolanta Piszczek, B. Dalton, T. Peters, D. Ruether +1 more
2014Clinical Genitourinary Cancer5 citations
Semantic Scholar
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC)
S. Parimi, M. Eliasziw, S. North, M. Trudeau +5 more
2016Investigational new drugs4 citations
Semantic Scholar
Randomized phase II trial of irofulven (IROF)/prednisone (P), IROF/capecitabine (C)/P or mitoxantrone (M)/P in docetaxel-pretreated hormone refractory prostate cancer (HRPC) patients (pts).
L. Hart, T. Ciuleanu, J. Hainsworth, S. Oudard +6 more
2006Journal of Clinical Oncology4 citations
Semantic Scholar
Radiation Exposure from GEP NET Surveillance
Jordan Iannuzzi, Caitlin T. Yeo, V. Parkins, D. Ruether +4 more
2024Cancers3 citations Open access
Semantic Scholar
Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study
R. Lee-Ying, D. O'Sullivan, R. Gagnon, N. Bosma +14 more
2022CMAJ Open3 citations Open access
Semantic Scholar
299 POSTER Randomized phase II trial of irofulven/prednisone, irofulven/capecitabine/prednisone, or mitoxantrone/prednisone in hormone refractory prostate cancer (HRPC) patients failing first-line docetaxel: preliminary results
L. Hart, J. Hainsworth, T. Ciuleanu, S. Oudard +6 more
20063 citations
Semantic Scholar
Creating and implementing a medical consultation recording app: Improving health information recall and shared decision-making with My Care Conversations
L. Watson, S. M. Anstruther, C. Link, S. Qi +2 more
2024Health Informatics Journal2 citations Open access
Semantic Scholar
Has Radiotherapy Been Successfully Implemented in Alberta’s Small Cities? A Review of Alberta’s Regional Cancer Centre Network from 2010–2020
P. Craighead, D. Ruether, C. Martens, P. Grendarova
2021Current Oncology2 citations Open access
Semantic Scholar
Multicenter phase II study of combined neoadjuvant docetaxel and androgen ablation (ADT) prior to radical prostatectomy (RP) for patients (pts) with high risk localized prostate cancer (LCaP): Pathologic outcomes and 3-year follow-up analyses
E. Winquist, K. Chi, J. Chin, L. Goldenberg +7 more
20072 citations
Semantic Scholar
Phase II study of neoadjuvant docetaxel and androgen suppression (AS) plus radiation therapy (RT) for high-risk localized prostate cancer (HRLCaP).
M. Mckenzie, Kim N. Chi, Alan J. Neville, S. Ellard +6 more
2006Journal of Clinical Oncology2 citations
Semantic Scholar
A phase II study of neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for resectable liver metastases from colorectal cancer
O. Bathe, S. Ernst, F. Sutherland, E. Dixon +6 more
20052 citations
Semantic Scholar
Providing audiotapes of primary adjuvant treatment consultations to men with prostate cancer: Impact on recall, mood, satisfaction, and quality of life.
Thomas F. Hack, Tom Pickles, B. Bultz, D. Ruether +1 more
2004Journal of Clinical Oncology2 citations
Semantic Scholar
Safe Prescribing Practices: Clinicians' Views on Prescribing Opioids to Patients With Early-Stage Cancer
T. Wood, W. Cheung, D. Ruether, Aynharan Sinnarajah +4 more
2023JCO Oncology Practice1 citations
Semantic Scholar
Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years
O. Abdel-Rahman, Truong-Minh Pham, A. Pokhrel, D. Ruether +1 more
2022American Journal of Clinical Oncology1 citations
Semantic Scholar
Phase II study of neoadjuvant docetaxel and androgen suppression (AS) plus radiation therapy (RT) for high-risk localized prostate cancer (HRLCaP)
M. Mckenzie, K. Chi, A. Neville, S. Ellard +5 more
20061 citations
Semantic Scholar
Implementing a Rapid Response Pathway for Anaplastic Thyroid Cancer in a Universal Healthcare System
Sana Ghaznavi, K. Mahboubi, Debbie Lamb, Kara Hawker +9 more
2026Laryngoscope Investigative Otolaryngology0 citations Open access
Semantic Scholar
Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011–2021)
A. Aleksi, K. Jobin, M. Hannouf, P. Husi +4 more
2026Current Oncology0 citations Open access
Semantic Scholar
Use of perioperative telotristat in a patient with carcinoid heart disease
Maria Flynn, Christopher D. Noss, R. Miller, Corey A. Adams +4 more
2024Endocrinology, Diabetes & Metabolism Case Reports0 citations Open access
Semantic Scholar
A Unique Case of Metastatic Recurrent Neuroendocrine Tumor in a Transplanted Liver Patient with Initial Diagnosis of Primary Well-Differentiated Intrahepatic Biliary Neuroendocrine Tumor
A. Aleksi, Joanna Mycek, D. Ruether, Ruban Gnanakumar
2023Annals of Case Reports0 citations Open access
Semantic Scholar
Imaging surveillance of completely resected gastroenteropancreatic neuroendocrine tumors is associated with high levels of radiation exposure
Jordan Ianuzzi, C. Yeo, V. Parkins, J. Pasieka +5 more
2022Endocrine Abstracts0 citations
Semantic Scholar
A Systematic Population-Based Approach to Identify Patients With NTRK Gene Fusion-Positive and RET Gene Fusion/Mutation-Positive Thyroid Cancers Who Could Benefit from Treatment With TRK or RET Inhibitors
M. Eszlinger, Paul Stewardson, J. McIntyre, A. Box +6 more
2021Canadian Journal of Diabetes0 citations
Semantic Scholar
Predicting symptom complexity: Using autoregressive integrated moving average (ARIMA) models to create responsive clinic scheduling.
L. Watson, S. Qi, A. Deiure, C. Link +5 more
20210 citations
Semantic Scholar
Canadian guideline on genetic screening for hereditary renal cell
M. Reaume, G. Graham, Eva Tomiak, S. Kamel-Reid +16 more
20130 citations
Semantic Scholar
Problems Identified With Phase II Stopping Rules That Employ Response and Early-Progression Rates
B. Szechtman, S. Berry, S. Huan, D. Ruether +1 more
20080 citations
Semantic Scholar
Haploidentical transplants using partial T-cell depletion, cyclosporin and low-dose antithymocyte globulin as gvhd prophylaxis
J. Russell, A. Chaudhry, P. Duggan, D. Stewart +12 more
20000 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Winquist×8
Invite
E. Winquist — researcher profile on SciRah
K. Chi×6
Invite
K. Chi — researcher profile on SciRah
S. North×6
Invite
S. North — researcher profile on SciRah
N. Blais×5
Invite
N. Blais — researcher profile on SciRah

×4

Invite

S. Qi — researcher profile on SciRah

Invite

C. Link — researcher profile on SciRah

Invite

C. Cuthbert — researcher profile on SciRah

Invite

S. Sridhar — researcher profile on SciRah

D. Soulières×3

Invite

D. Soulières — researcher profile on SciRah

G. Bjarnason×3

Invite

G. Bjarnason — researcher profile on SciRah

Invite

J. Lattouf — researcher profile on SciRah

Invite

L. Wood — researcher profile on SciRah